S2k-Leitlinie Neuroendokrine Tumore: AWMF-Reg. 021-27

Translated title of the contribution: Practice guideline neuroendocrine tumors: AWMF-Reg021-27

Thomas Mathias Gress, Jörg Albert, Heiko Alfke, Holger Amthauer, Martin Anlauf, Rudolf Arnold, Richard Baum, Timm Denecke, Samer Ezziddin, Volker Fendrich, Stefan Gniffke, Alexander Haug, Dieter Hörsch, Thomas Kegel, Wolfram Trudo Knoefel, Thomas Knösel, Clemens Kratochwil, Harald Lahner, Florian Lordick, Markus LusterAndreas Mahnken, Katharina Mellar, Heiner Mönig, Thomas J. Musholt, Monika Nothacker, Ulrich Frank Pape, Andreas Pascher, Thorsten Pöppel, Vikas Prasad, Andreas Probst, Klemens Scheidhauer, Dominik Schneider, Matthias Schott, Jörg Schrader, Thomas Seufferlein, Bence Sipos, Christine Spitzweg, Thomas Steinmüller, Christoph Trumm, Christine Wurst, Niels Zorger

Research output: Contribution to journalArticlepeer-review

60 Scopus citations


This guideline was created for the first time and is intended as a practical aid for the diagnosis and therapy of neuroendocrine tumors. The aim is to represent the current state of science, promote the recognition of the disease and improve the treatment of patients. The guideline was created under the leadership of the DGVS and with participation of neighbouring scientific societies.

Translated title of the contributionPractice guideline neuroendocrine tumors: AWMF-Reg021-27
Original languageGerman
Pages (from-to)583-681
Number of pages99
JournalZeitschrift fur Gastroenterologie
Issue number6
StatePublished - Jun 1 2018


  • Gastrinoma
  • Gastroenterpancreatic tumour
  • Insulinoma
  • MEN (multiple endocrine neoplasia)
  • NEN (neuroendocrine neoplasia)
  • NET (neuroendocrine tumour)


Dive into the research topics of 'Practice guideline neuroendocrine tumors: AWMF-Reg021-27'. Together they form a unique fingerprint.

Cite this